CHA
VTRS icon

Carmichael Hill & Associates’s Viatris VTRS Stock Holding History

Carmichael Hill & Associates’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$16K Sell
1,381
-53
-4% -$611 0.01% 533
2024
Q2 		$15.2K Buy
1,434
+181
+14% +$2K 0.01% 517
2024
Q1 		$15K Sell
1,253
-12
-0.9% -$145 0.01% 515
2023
Q4 		$13.7K Buy
1,265
+56
+5% +$536 0.01% 531
2023
Q3 		$11.9K Buy
1,209
+53
+5% +$552 0.01% 541
2023
Q2 		$11.5K Buy
1,156
+100
+9% +$955 0.01% 547
2023
Q1 		$10.2K Buy
1,056
+46
+5% +$510 ﹤0.01% 555
2022
Q4 		$11.2K Buy
1,010
+1
+0.1% +$10 0.01% 536
2022
Q3 		$9K Buy
1,009
+100
+11% +$984 ﹤0.01% 598
2022
Q2 		$10K Buy
909
+125
+16% +$1.37K 0.01% 570
2022
Q1 		$9K Buy
784
+19
+2% +$250 ﹤0.01% 623
2021
Q4 		$10K Sell
765
-130
-15% -$1.74K ﹤0.01% 623
2021
Q3 		$12K Sell
895
-208
-19% -$2.95K 0.01% 584
2021
Q2 		$16K Sell
1,103
-104
-9% -$1.5K 0.01% 546
2021
Q1 		$17K Sell
1,207
-372
-24% -$6.06K 0.01% 521
2020
Q4 		$30K Buy
+1,579
New +$25.8K 0.02% 409

Other funds holding VTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Carmichael Hill & Associates's VTRS Position: Q3 2024 in Review

Carmichael Hill & Associates reduced its Viatris (VTRS) stake by 3.7% in Q3 2024, selling an estimated $611 and leaving 1,381 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #533.

Carmichael Hill & Associates first reported a position in VTRS in Q4 2020 and has held it in 16 quarters since. The position peaked at $30K in Q4 2020. 1,000 funds tracked by Wall St. Rank hold VTRS as of Q3 2024.

  • Carmichael Hill & Associates held 1,381 shares of Viatris worth $16K as of Q3 2024.
  • Carmichael Hill & Associates sold 53 Viatris shares in Q3 2024, an estimated $611.
  • Viatris made up 0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #533 holding.
  • Carmichael Hill & Associates first reported a position in Viatris in Q4 2020 and has held it in 16 quarters since.
  • Carmichael Hill & Associates's Viatris position peaked at $30K in Q4 2020.
  • 1,000 funds tracked by Wall St. Rank held Viatris as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.